Purification of coagulation factor VIII using chromatographic methods. Direct chromatography of plasma in anion exchange resins
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
20/10/2012
20/10/2012
2010
|
Resumo |
Coagulation factor VIII (FVIII) concentrates are used in the treatment of patients with Hemophilia A. Human FVIII was purified directly from plasma using anion exchange chromatography followed by gel filtration. Three Q-Sepharose resins were tested, resulting in 40% recovery of FVIII activity using Q-Sepharose XL resin, about 80% using Q-Sepharose Fast Flow and 70% using the Q-Sepharose Big Beads. The vitamin K-dependent coagulation factors co-eluted with FVIII from the anion exchange columns. In the second step of purification, when Sepharose 6FF was used, 70% of FVIII activity was recovered free from vitamin K-dependent factors. Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Programa de Aprimoramento Profissional (FUNDAP) Programa de Aprimoramento Profissional (FUNDAP) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Fundacao Butantan Fundacao Butantan |
Identificador |
BIOTECHNOLOGY LETTERS, v.32, n.9, p.1207-1214, 2010 0141-5492 http://producao.usp.br/handle/BDPI/32195 10.1007/s10529-010-0282-0 |
Idioma(s) |
eng |
Publicador |
SPRINGER |
Relação |
Biotechnology Letters |
Direitos |
restrictedAccess Copyright SPRINGER |
Palavras-Chave | #Anion exchange #Coagulation factors #Factor VIII/von Willebrand complexes #Gel filtration #Plasma protein #Purification #VON-WILLEBRAND-FACTOR #HEMOPHILIA-A #FACTOR-IX #CRYOPRECIPITATE #FRACTIONATION #INHIBITOR #PROTEINS #Biotechnology & Applied Microbiology |
Tipo |
article original article publishedVersion |